Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Vitiligo treatments are improving but relapses are common.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Reducing nerve growth can help skin regenerate after birth.

Cetuximab can cause excessive eyelash growth.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Online articles about alopecia areata are too hard to understand and need to be clearer.

Ruxolitinib can cause a delayed skin reaction on the nose.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

New cancer drugs often cause skin and nail problems.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.